雪榕生物(300511.SZ)2021年度預虧2.38億-3.1億元 同比盈轉虧
格隆匯1月24日丨雪榕生物(300511.SZ)公佈,預計2021年度歸屬於上市公司股東的淨虧損2.38億元-3.1億元,上年同期為盈利24724.18萬元;歸屬於上市公司股東的扣除非經常性損益後的淨虧損2.36億元-3.08億元,上年同期為盈利23902.87萬元。
業績變動原因:1、報吿期內,食用菌市場行情整體下行,尤其是公司主要產品金針菇,銷售價格同比下降較多;受大宗貨物貿易影響,主要原材料採購價格上漲明顯,公司產品單位成本上升;公司泰國生產基地受當地疫情影響,對泰國項目的生產銷售產生重大不利影響,導致虧損嚴重擴大。
2、根據《企業會計準則第8號-資產減值》及相關會計政策規定,結合實際經營情況、行業市場變化、競爭格局及資產運行情況,基於謹慎性原則,公司判斷報吿期內相關資產出現減值(跌價)跡象,經公司財務部門的初步測試,預計對相關資產計提減值(跌價)準備金額約1.3億元-2億元(最終數據以審計報吿為準)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.